In cancer immunity, antigen presentation to CD8+ T cells is mediated by major histocompatibility complex class I (MHC class I) molecules on the cell surface, and an elevated expression of MHC class I molecules generally promotes the activation of CD8+ T cells [7,8]. Here, CD8A is linked to cancer.